Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-07-25
1995-10-10
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514557, 514573, A61K 3119, A61K 3120
Patent
active
054571308
ABSTRACT:
The use of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid or EPA, preferably substantially free of any other polyunsaturated fatty acids, is disclosed for making up medical preparations or compositions for the treatment of cachexia by inhibiting lipolytic activity of biologically active lipolytic agents present in body fluids and the activity of the enzyme guanidinobenzoatase, as well as for reducing abnormal cAMP levels in cells of adipose tissue in mammals, produced by lipolytic or fat mobilizing substances.
REFERENCES:
patent: 4835183 (1989-05-01), Yamatsu et al.
patent: 4954525 (1990-09-01), Yamatsu et al.
patent: 4960795 (1990-10-01), Salte et al.
Laustiola et al, Biochimica et Biophysica Acta, vol. 889, 1986, Elsevier Science Publishers B.V.
Karmall et al, J.N.C.J., vol. 73, No. 2, Aug., 1984.
Begin et al, Prostaglandins Leukotrienes and Medicine, vol. 19, 1985.
Booyens et al, IRCS Medical Science, vol. 14, No. 4, 1986.
Steven et al, J. Enzym. Inhib., vol. 1, No. 2, 1987.
Beck Susan A.
Tisdale Michael J.
Cancer Research Campaign - Technology Limited
Criares Theodore J.
LandOfFree
Eicosapentaenoic acid used to treat cachexia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eicosapentaenoic acid used to treat cachexia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eicosapentaenoic acid used to treat cachexia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310693